Supplementary Figure 2 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Hashimoto T., Nakamura Y., Fujisawa T., Imai M., Shibuki T., Iida N., Ozaki H., Nonomura N., Morizane C., Iwata H., Okano S., Yamagami W., Yamazaki N., Kadowaki S., Taniguchi H., Ueno M., Boku S., Oki E., Komatsu Y., Yuki S., Makiyama A., Otsuka T., Hara H., Okano N., Nishina T., Sakamoto Y., Miki I., Kobayashi S., Yuda J., Kageyama S-I., Nagamine M., Sakashita S., Sakamoto N., Yamashita R., Koga Y., Bando H., Ishii G., Kuwata T., Park W-Y., Ohtsu A., Yoshino T.
Comparison of overall survival between patients receiving matched therapy vs. those not receiving matched therapy among patients with any targets recommended for matched therapy.